SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-018617
Filing Date
2019-05-13
Accepted
2019-05-10 17:39:42
Documents
70
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q insy-10q_20190331.htm 10-Q 2306332
2 EX-10.1 insy-ex101_221.htm EX-10.1 107611
3 EX-31.1 insy-ex311_8.htm EX-31.1 9112
4 EX-31.2 insy-ex312_7.htm EX-31.2 9010
5 EX-32 insy-ex32_6.htm EX-32 9107
  Complete submission text file 0001564590-19-018617.txt   9909409

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT insy-20190331.xml EX-101.INS 2639230
7 XBRL TAXONOMY EXTENSION SCHEMA insy-20190331.xsd EX-101.SCH 52796
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE insy-20190331_cal.xml EX-101.CAL 67229
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE insy-20190331_def.xml EX-101.DEF 175422
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE insy-20190331_lab.xml EX-101.LAB 447902
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE insy-20190331_pre.xml EX-101.PRE 339156
Mailing Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044
Business Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044 602-910-2617
Insys Therapeutics, Inc. (Filer) CIK: 0001516479 (see all company filings)

IRS No.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35902 | Film No.: 19816216
SIC: 2834 Pharmaceutical Preparations